Katsunori Yanagihara

Katsunori Yanagihara publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Katsunori Yanagihara sits on this spectrum.

Katsunori Yanagihara D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Katsunori Yanagihara sits on this spectrum.

Best Publications

• M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1/M2 Monocytes to Osteoclastogenesis.

  Shoichi Fukui;Naoki Iwamoto;Ayuko Takatani;Takashi Igawa

  218
  Citations

• Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells

  Tetsuya Usui;Katsunori Yanagihara;Kunihiro Tsukasaki;Ken Murata

  165
  Citations

• Azithromycin Inhibits MUC5AC Production Induced by the Pseudomonas aeruginosa Autoinducer N-(3-Oxododecanoyl) Homoserine Lactone in NCI-H292 Cells

  Unknown

  163
  Citations

• Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit

  Katsunori Yanagihara;Yuko Kitagawa;Masao Tomonaga;Kunihiro Tsukasaki

  144
  Citations

• Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy.

  Daisuke Sasaki;Yoshitaka Imaizumi;Hiroo Hasegawa;Akemi Osaka

  141
  Citations

• Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells

  K. Sugiyama;R. Shirai;H. Mukae;H. Ishimoto

  132
  Citations

• Clinical and Bacteriological Characteristics of IMP-Type Metallo-β-Lactamase-Producing Pseudomonas aeruginosa

  Yoichi Hirakata;Toshiyuki Yamaguchi;Michiko Nakano;Koichi Izumikawa

  132
  Citations

• Azithromycin Exhibits Bactericidal Effects on Pseudomonas aeruginosa through Interaction with the Outer Membrane

  Yoshifumi Imamura;Yasuhito Higashiyama;Kazunori Tomono;Koichi Izumikawa

  126
  Citations

• Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus

  Masato Tashiro;Koichi Izumikawa;Katsuji Hirano;Shotaro Ide

  123
  Citations

• Roles of Calcineurin and Crz1 in Antifungal Susceptibility and Virulence of Candida glabrata

  Unknown

  121
  Citations

• Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature.

  Koichi Izumikawa;Kinichi Izumikawa;Takahiro Takazono;Kosuke Kosai

  116
  Citations

• JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG

  Unknown

  114
  Citations

• Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan

  Masato Tashiro;Koichi Izumikawa;Asuka Minematsu;Katsuji Hirano

  109
  Citations

• ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries

  Ronald N. Jones;Shigeru Kohno;Yasuo Ono;James E. Ross

  101
  Citations

• Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model

  Katsunori Yanagihara;Kazunori Tomono;Yoshifumi Imamura;Yukihiro Kaneko

  100
  Citations

• Japanese guidelines for the management of community-acquired pneumonia.

  K Yanagihara;S Kohno;T Matsusima

  100
  Citations

• Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward.

  Takayoshi Tashiro;Koichi Izumikawa;Masato Tashiro;Takahiro Takazono

  100
  Citations

• Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens’ antibacterial susceptibility

  Akira Watanabe;Katsunori Yanagihara;Tetsuya Matsumoto;Shigeru Kohno

  99
  Citations

• Clinical features of pulmonary cryptococcosis in non-HIV patients in Japan

  Unknown

  93
  Citations

• Strong Evidence of a Combination Polymorphism of the Tyrosine Kinase 2 Gene and the Signal Transducer and Activator of Transcription 3 Gene as a DNA-Based Biomarker for Susceptibility to Crohn’s Disease in the Japanese Population

  Kayoko Sato;Mizuho Shiota;Sayaka Fukuda;Eiko Iwamoto

  92
  Citations